Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy

被引：0
|
作者：
C G McMahon
机构：
[1] Australian Centre for Sexual Health,
来源：
International Journal of Impotence Research | 2003年 / 15卷
关键词：
erectile dysfunction; priapism; sildenafil; tadalafil; penile injections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：383 / 384
页数：1
相关论文
共 50 条
  • [41] Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
    Anderson, Simon G.
    Hutchings, David C.
    Woodward, Mark
    Rahimi, Kazem
    Rutter, Martin K.
    Kirby, Mike
    Hackett, Geoff
    Trafford, Andrew W.
    Heald, Adrian H.
    HEART, 2016, 102 (21) : 1750 - 1756
  • [42] Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015
    Gillmeyer, Kari R.
    Rinne, Seppo T.
    Glickman, Mark E.
    Lee, Kyung Min
    Shao, Qing
    Qian, Shirley X.
    Klings, Elizabeth S.
    Maron, Bradley A.
    Hanlon, Joseph T.
    Miller, Donald R.
    Wiener, Renda Soylemez
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (05): : 216 - 227
  • [43] Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model
    Prebble, Amber R.
    Latka, Bailey
    Burdekin, Braden
    Leary, Del
    Harris, Mac
    Regan, Daniel
    Boss, Mary-Keara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [44] Screening for multiple phosphodiesterase type 5 inhibitor drugs in dietary supplement materials by flow injection mass spectrometry and their quantification by liquid chromatography tandem mass spectrometry
    Song, Fenhong
    El-Demerdash, Aref
    Lee, Shwn-Ji Susie H.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 40 - 46
  • [45] Frequent Cannabis Use Is Negatively Associated with Frequency of Injection Drug Use Among People Who Inject Drugs in a Canadian Setting
    Reddon, Hudson
    DeBeck, Kora
    Socias, Maria-Eugenia
    Lake, Stephanie
    Dong, Huiru
    Hayashi, Kanna
    Milloy, Michael-John
    CANNABIS AND CANNABINOID RESEARCH, 2021, 6 (05) : 435 - 445
  • [46] Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes
    Shanker, Mihir D.
    Garimall, Sidyarth
    Gatt, Nick
    Foley, Heath
    Crowley, Samuel
    Le Cornu, Emma
    Muscat, Kendall
    Soon, Wei
    Atkinson, Victoria
    Xu, Wen
    Watkins, Trevor
    Huo, Michael
    Foote, Matthew C.
    Pinkham, Mark B.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2022, 66 (04) : 536 - 545
  • [47] Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy
    Farrugia, Mark K.
    Long, Mark D.
    Mattson, David M.
    Flaherty, Leayn T.
    Dong, Bowen
    Cortes Gomez, Eduardo
    Wei, Lei
    Witkiewicz, Agnieszka K.
    Yao, Song
    Kalinski, Pawel
    Singh, Anurag K.
    CANCERS, 2021, 13 (02) : 1 - 13
  • [48] Calcineurin Inhibitor and Nonsteroidal Anti-inflammatory Drug Interaction: Implications of Changes in Renal Function Associated With Concurrent Use
    Delzer, Luke M.
    Golightly, Larry K.
    Kiser, Tyree H.
    Biggins, Scott W.
    Lewis, Victor J.
    Kim, Ike I.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1443 - 1451
  • [49] Phosphodiesterase Type 5 inhibitor use and drug interactions in HIV-infected US air force members receiving antiretroviral therapy
    Cota, Jason M.
    James, Michael A.
    Li, Julius
    Okulicz, Jason F.
    PHARMACOTHERAPY, 2017, 37 (12): : E179 - E179
  • [50] Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use
    Palepu, A
    Tyndall, M
    Yip, B
    O'Shaughnessy, MV
    Hogg, RS
    Montaner, JSG
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) : 522 - 526
12345